Ken Griffin Verona Pharma PLC Put Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Put Options
7 transactions
Others Institutions Holding VRNA
# of Institutions
150Shares Held
67.5MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$291 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$213 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$153 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$136 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$127 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.33B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...